End-of-day quote
Taiwan S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
17.3
TWD
|
+0.58%
|
|
+1.76%
|
-14.14%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
18,311
|
17,701
|
19,536
|
16,305
|
17,663
|
15,165
|
Enterprise Value (EV)
1 |
31,693
|
31,056
|
19,536
|
16,305
|
17,663
|
15,165
|
P/E ratio
|
525
x
|
-16.6
x
|
21.7
x
|
465
x
|
67.2
x
|
47.4
x
|
Yield
|
1.43%
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.82
x
|
0.95
x
|
0.71
x
|
-
|
0.85
x
|
0.73
x
|
EV / Revenue
|
0.82
x
|
0.95
x
|
0.71
x
|
-
|
0.85
x
|
0.73
x
|
EV / EBITDA
|
256,599,529
x
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-15.9
x
|
74.3
x
|
5.31
x
|
-
|
2,137
x
|
192
x
|
FCF Yield
|
-6.31%
|
1.35%
|
18.8%
|
-
|
0.05%
|
0.52%
|
Price to Book
|
1.38
x
|
1.46
x
|
1.55
x
|
-
|
1.53
x
|
1.24
x
|
Nbr of stocks (in thousands)
|
871,949
|
871,949
|
872,134
|
876,594
|
876,594
|
876,594
|
Reference price
2 |
21.00
|
20.30
|
22.40
|
18.60
|
20.15
|
17.30
|
Announcement Date
|
3/25/20
|
3/18/21
|
3/9/22
|
3/10/23
|
3/7/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
22,318
|
18,714
|
27,467
|
-
|
20,817
|
20,718
|
EBITDA
|
71.36
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-1,011
|
-456
|
1,422
|
-
|
-680.5
|
250
|
Operating Margin
|
-4.53%
|
-2.44%
|
5.18%
|
-
|
-3.27%
|
1.21%
|
Earnings before Tax (EBT)
1 |
-667.9
|
-1,307
|
1,375
|
-
|
-196.4
|
226
|
Net income
1 |
33.62
|
-1,065
|
899.8
|
-
|
265.7
|
322
|
Net margin
|
0.15%
|
-5.69%
|
3.28%
|
-
|
1.28%
|
1.55%
|
EPS
2 |
0.0400
|
-1.220
|
1.030
|
0.0400
|
0.3000
|
0.3650
|
Free Cash Flow
1 |
-1,155
|
238.3
|
3,678
|
-
|
8.266
|
79
|
FCF margin
|
-5.17%
|
1.27%
|
13.39%
|
-
|
0.04%
|
0.38%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
408.74%
|
-
|
3.11%
|
24.53%
|
Dividend per Share
|
0.3000
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/25/20
|
3/18/21
|
3/9/22
|
3/10/23
|
3/7/24
|
-
|
Fiscal Period: December |
2021 Q3
|
2022 Q1
|
2022 Q2
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
---|
Net sales
1 |
6,975
|
6,525
|
5,519
|
5,225
|
5,235
|
5,248
|
5,086
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
378.5
|
-136.3
|
-327.6
|
-130.8
|
-141.6
|
-248.3
|
-159.8
|
Operating Margin
|
5.43%
|
-2.09%
|
-5.94%
|
-2.5%
|
-2.7%
|
-4.73%
|
-3.14%
|
Earnings before Tax (EBT)
1 |
292.3
|
-288.8
|
-467.2
|
521.3
|
-194
|
-275.2
|
-248.5
|
Net income
1 |
229.1
|
-73.16
|
-187.7
|
629.9
|
-75.77
|
-148.8
|
-139.6
|
Net margin
|
3.28%
|
-1.12%
|
-3.4%
|
12.06%
|
-1.45%
|
-2.84%
|
-2.74%
|
EPS
2 |
0.2600
|
-0.0800
|
-0.2200
|
0.7200
|
-0.0900
|
-0.1700
|
-0.1600
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/5/21
|
4/29/22
|
8/5/22
|
4/28/23
|
8/11/23
|
11/10/23
|
3/7/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2023
|
2024
|
---|
Net Debt
|
13,382
|
13,355
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
187.5
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-1,155
|
238
|
3,678
|
8.27
|
79
|
ROE (net income / shareholders' equity)
|
0.24%
|
-
|
7.22%
|
2.24%
|
1.8%
|
ROA (Net income/ Total Assets)
|
0.09%
|
-
|
2.65%
|
0.78%
|
0.8%
|
Assets
1 |
36,621
|
-
|
33,940
|
33,963
|
40,250
|
Book Value Per Share
2 |
15.30
|
13.90
|
14.50
|
13.20
|
13.90
|
Cash Flow per Share
|
-0.8900
|
0.8600
|
-
|
-
|
-
|
Capex
1 |
408
|
513
|
13.7
|
26.7
|
16
|
Capex / Sales
|
1.83%
|
2.74%
|
0.05%
|
0.13%
|
0.08%
|
Announcement Date
|
3/25/20
|
3/18/21
|
3/9/22
|
3/7/24
|
-
|
Last Close Price
17.3
TWD Average target price
21
TWD Spread / Average Target +21.39% Consensus |
1st Jan change
|
Capi.
|
---|
| -14.14% | 465M | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.24B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|